Clinical and prognostic significance of concanavalin-Ainduced suppressor cell activity in malignant cervical neoplasia
- 1 April 1990
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 97 (4) , 357-361
- https://doi.org/10.1111/j.1471-0528.1990.tb01815.x
Abstract
Peripheral blood lymphocytes from patients with different stages of cancer of the uterine cervix were analysed for concanavalin-A-induced suppressor cell activity. All cancer patients had high levels of suppressor activity, the increase corresponding to tumour load. Radiotherapy resulted in further increase of suppressor activity. About six months after radiotherapy, patients who remained disease free returned to pretreatment levels of suppressor cell activity and later showed even lewer levels of suppression. On the other hand, patients who developed recurrent disease maintained sustained high levels of suppression and for all stages they always had higher suppressor activity than the patients who remained disease free in the corresponding stage. These results stress the importance of a possible deranged immune system in these patients and also shows the clinical and prognostic significance of the assay.This publication has 15 references indexed in Scilit:
- Immune function in malignant cervical neoplasia: A multiparameter analysisGynecologic Oncology, 1988
- Natural Cytotoxicity and Serum Blocking in Malignant Cervical NeoplasiaAmerican Journal of Reproductive Immunology, 1988
- Monoclonal Antibody Defined Phenotypes of Peripheral Blood Lymphocytes in Cancer of the Uterine CervixAmerican Journal of Reproductive Immunology, 1987
- Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte populationInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Defective suppressor cell activity in cancer patients: A defect in immune regulationCancer, 1981
- Clinical studies on cell-mediated immunity in patients with malignant diseaseCancer Immunology, Immunotherapy, 1980
- Characteristics and mechanisms of action of the concanavalin A-activated suppressor cell in manCellular Immunology, 1979
- Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.The Journal of Experimental Medicine, 1976
- INHIBITORY AND STIMULATORY EFFECTS OF CONCANAVALIN A ON THE RESPONSE OF MOUSE SPLEEN CELL SUSPENSIONS TO ANTIGENThe Journal of Experimental Medicine, 1972
- The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel FiltrationScandinavian Journal of Clinical and Laboratory Investigation, 1968